Lynn Marie Ploughman

Title: Lynn Marie Ploughman: Innovator in Cardiovascular Genetics

Introduction

Lynn Marie Ploughman is a notable inventor based in Washington Crossing, PA (US). She has made significant contributions to the field of genetics, particularly in understanding cardiovascular disorders. With a total of 3 patents, her work has the potential to impact the treatment and detection of cardiovascular diseases.

Latest Patents

One of her latest patents focuses on genetic polymorphisms associated with cardiovascular disorders and drug response. This invention is based on the discovery of genetic polymorphisms linked to acute coronary events, such as myocardial infarction and stroke. It also addresses how individuals respond to treatment for cardiovascular disorders with statins. The patent details nucleic acid molecules containing these polymorphisms, variant proteins encoded by them, and reagents for their detection. Methods for utilizing these nucleic acids and proteins are also included, showcasing the practical applications of her research.

Career Highlights

Lynn has worked with prominent companies in the pharmaceutical and biotechnology sectors, including Celera Corporation and Bristol-Myers Squibb Company. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Lynn has collaborated with notable colleagues, including Olga Iakoubova and James J. Devlin. These partnerships have enriched her work and expanded the impact of her inventions.

Conclusion

Lynn Marie Ploughman is a pioneering inventor whose work in genetic polymorphisms is paving the way for advancements in cardiovascular medicine. Her contributions are vital for improving patient outcomes and enhancing our understanding of genetic influences on health.